Nationwide Children's Hospital
Clinical trials sponsored by Nationwide Children's Hospital, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study aims to predict deadly gut infection in preemies before symptoms appear Results expected Sep 2026 (estimated)
- A gentle zap to the ear might calm gut pain in teens Results expected Oct 2026 (estimated)
- New online program aims to help families of childhood cancer survivors thrive Results expected Nov 2026 (estimated)
- Can a fun AR game ease kids' pain during emergency IVs? Results expected Nov 2026 (estimated)
- Immune booster: could donor NK cells help kids beat sarcoma? Results expected Dec 2026 (estimated)
-
Promising drug combo targets aggressive brain cancers in youth
Disease control Not yet recruitingThis study is for adolescents and young adults (ages 12-39) newly diagnosed with aggressive brain tumors called high-grade glioma or DIPG. The goal is to see if a combination of two immunotherapy drugs (relatlimab and nivolumab, sold as Opdualag) is safe and tolerable when given …
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New hope for kids with deadly brain cancer: targeted drug trial launches
Disease control Not yet recruitingThis study tests a drug called tovorafenib in children and young adults (ages 1 to 39) newly diagnosed with aggressive brain tumors (high-grade glioma or DIPG) that have specific genetic changes. The goal is to see if the drug can help them live longer. About 79 participants will…
Phase 2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Brain tumor trial aims to find kinder chemo for toddlers
Disease control Not yet recruitingThis phase 3 trial compares two standard chemotherapy regimens for children under 5 with a low-risk type of medulloblastoma. The main goal is to see which approach better protects thinking and learning skills 2.5 years after diagnosis. The study will also track survival and side …
Phase 3 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Donor cells take on tough leukemia in new trial
Disease control Not yet recruitingThis study tests a new treatment for acute myeloid leukemia (AML) that has returned or not responded to standard therapy. It uses specially modified immune cells from a healthy donor to attack the cancer. The first part finds the safest dose, and the second part checks how well i…
Phase 1/2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New Parent-Led program aims to help sick babies ditch feeding tubes
Symptom relief Not yet recruitingThis study tests a new program where parents help their hospitalized infants with swallowing difficulties learn to eat by mouth. The goal is to reduce the need for feeding tubes and improve the baby's feeding reflexes. About 134 infants will take part, and researchers will track …
Sponsor: Nationwide Children's Hospital • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
VR pain relief for kids: scientists scan brains to see how it works
Knowledge-focused Not yet recruitingThis study will use a special brain scanner to see how virtual reality (VR) affects pain in children aged 6-17 with burns. Four children will have their brain activity measured during burn dressing changes, both with and without VR. The goal is to find brain markers that show whe…
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Sep 11, 2026 00:00 UTC